OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
New therapeutic modalities in drug discovery and development: Insights & opportunities
Manfred Kansy, Giulia Caron
ADMET & DMPK (2021) Vol. 9, Iss. 4, pp. 227-230
Open Access | Times Cited: 7
Manfred Kansy, Giulia Caron
ADMET & DMPK (2021) Vol. 9, Iss. 4, pp. 227-230
Open Access | Times Cited: 7
Showing 7 citing articles:
PROTAC technology: A new drug design for chemical biology with many challenges in drug discovery
Nicolas Guedeney, Marie Cornu, Florian Schwalen, et al.
Drug Discovery Today (2022) Vol. 28, Iss. 1, pp. 103395-103395
Open Access | Times Cited: 62
Nicolas Guedeney, Marie Cornu, Florian Schwalen, et al.
Drug Discovery Today (2022) Vol. 28, Iss. 1, pp. 103395-103395
Open Access | Times Cited: 62
The role of the efflux transporter, P‐glycoprotein, at the blood–brain barrier in drug discovery
Benoit Cox, Johan Nicolaï, Beth Williamson
Biopharmaceutics & Drug Disposition (2022) Vol. 44, Iss. 1, pp. 113-126
Closed Access | Times Cited: 18
Benoit Cox, Johan Nicolaï, Beth Williamson
Biopharmaceutics & Drug Disposition (2022) Vol. 44, Iss. 1, pp. 113-126
Closed Access | Times Cited: 18
Impact of Post Manufacturing Handling of Protein-Based Biologic Drugs on Product Quality and User Centricity
Elia Cappelletto, Stanley C. Kwok, Léa Sorret, et al.
Journal of Pharmaceutical Sciences (2024) Vol. 113, Iss. 8, pp. 2055-2064
Open Access | Times Cited: 2
Elia Cappelletto, Stanley C. Kwok, Léa Sorret, et al.
Journal of Pharmaceutical Sciences (2024) Vol. 113, Iss. 8, pp. 2055-2064
Open Access | Times Cited: 2
Oral Absorption of Middle-to-Large Molecules and Its Improvement, with a Focus on New Modality Drugs
Daigo Asano, Hideo Takakusa, Daisuke Nakai
Pharmaceutics (2023) Vol. 16, Iss. 1, pp. 47-47
Open Access | Times Cited: 7
Daigo Asano, Hideo Takakusa, Daisuke Nakai
Pharmaceutics (2023) Vol. 16, Iss. 1, pp. 47-47
Open Access | Times Cited: 7
The Potential Impact of New Drug and Therapeutic Modalities on Drug Resistance to Renal Cell Carcinoma
Pedro Caetano-Pinto
Anticancer Research (2023) Vol. 43, Iss. 3, pp. 983-991
Open Access | Times Cited: 5
Pedro Caetano-Pinto
Anticancer Research (2023) Vol. 43, Iss. 3, pp. 983-991
Open Access | Times Cited: 5
How are we handling protein drugs in hospitals? A Human Factors and Systems Engineering Approach to compare two hospitals and suggest a best practice
Clàudia Sabaté-Martínez, Mattias Paulsson, Silvia González-Suárez, et al.
International Journal for Quality in Health Care (2024) Vol. 36, Iss. 1
Open Access | Times Cited: 1
Clàudia Sabaté-Martínez, Mattias Paulsson, Silvia González-Suárez, et al.
International Journal for Quality in Health Care (2024) Vol. 36, Iss. 1
Open Access | Times Cited: 1
Expanding the Analytical Toolbox: Developing New Lys-C Peptide Mapping Methods with Minimized Assay-Induced Artifacts to Fully Characterize Antibodies
Diana Liu, Michelle Irwin Beardsley, Feng Yang
Pharmaceuticals (2023) Vol. 16, Iss. 9, pp. 1327-1327
Open Access | Times Cited: 2
Diana Liu, Michelle Irwin Beardsley, Feng Yang
Pharmaceuticals (2023) Vol. 16, Iss. 9, pp. 1327-1327
Open Access | Times Cited: 2
